Diagnostic utility of IMP3 expression in thyroid neoplasms: a quantitative RT-PCR study

Area of Science:

• Endocrinology
• Oncology
• Molecular Biology

Background:

• Differentiating benign from malignant well-differentiated thyroid tumors using molecular markers is challenging.
• Insulin-like growth factor II mRNA binding protein-3 (IMP3) is a potential diagnostic marker.

Purpose of the Study:

• To evaluate the diagnostic utility of IMP3 mRNA expression for distinguishing benign from malignant well-differentiated thyroid tumors.
• To assess IMP3 mRNA as a molecular marker in thyroid cancer diagnosis.

Main Methods:

• Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed on 80 thyroid tissue samples.
• IMP3 mRNA expression levels were analyzed and normalized against normal thyroid RNA.
• Conventional RT-PCR and immunohistochemistry were used for validation in a subset of cases.

Main Results:

• Thyroid carcinomas (papillary, follicular variants, follicular) exhibited significantly higher IMP3 mRNA expression (48.3, 35.3, 43.8 fold) compared to benign lesions (2.8 fold).
• A cutoff value of 5 fold for IMP3 expression demonstrated 91.4% specificity and 86.7% sensitivity for well-differentiated thyroid carcinomas.
• RT-PCR and immunohistochemical analyses corroborated the qRT-PCR findings.

Conclusions:

• IMP3 mRNA expression, detected by qRT-PCR, serves as a valuable molecular marker for diagnosing well-differentiated thyroid carcinomas.
• IMP3 shows potential to improve the accuracy in differentiating malignant from benign thyroid tumors.
• This molecular approach may assist clinicians in thyroid cancer diagnosis.